The company’s trial of Haduvio met its primary and secondary endpoints in reducing coughing fits across patients by 53%.

GOTHENBURG, SE / ACCESS Newswire / March 12, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, March 12, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and ...

GOTHENBURG, SE / ACCESS Newswire / March 12, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, March 12, 2025 - IRLAB Therapeutics AB , a company discovering and developing novel ...

The Phase Ib and Phase IIa studies showed a good safety and tolerability ... effect compared with current treatment options. A Phase IIb study, completed in 2023, showed that mesdopetam has ...

Degrees Pharmaceuticals (NASDAQ:SXTP – Get Free Report)‘s stock had its “sell (e+)” rating reaffirmed by research analysts at Weiss Ratings in a report issued on Friday,Weiss Ratings reports.

Results from the company’s Phase IIa double-blind, placebo-controlled River trial (NCT05962151 ... Elsewhere in the field of IPF, Pliant Therapeutics has terminated a Phase IIb trial of bexotegrast ...

ViiV Healthcare, majority owned by GSK (GSK), with Pfizer (PFE) (PE) and Shionogi as shareholders, announced findings from the company’s ...

See what moon phase it is tonight and find out when you can see the rest of the moon phases for 2025. Today, March 13, 2025, the moon is 12 days old and is in the Full Moon phase of its lunar cycle.